Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II trials assess belinostat in bladder cancer and hepatocellular carcinoma

Oct. 24, 2011

Pazopanib activity reported in soft tissue sarcoma and urothelial cancer

Oct. 24, 2011

Critical Outcome Technologies reports promising preclinical data on COTI-2

Oct. 21, 2011

OncoGenex Pharmaceuticals begins enrollment in OGX-427 study

Oct. 21, 2011

Novel nitroxyl-releasing agents synthesized in U.S.

Oct. 21, 2011

Kinagen claims new protein kinase inhibitors

Oct. 21, 2011

Further phase I data reported on GDC-941 in metastatic and advanced cancer

Oct. 21, 2011

Analysis of TIRASMUS data identifies possible marker of temsirolimus efficacy in colorectal cancer

Oct. 21, 2011

German research team presents new cyclin-dependent kinase 9 inhibitors

Oct. 21, 2011

FDA opens Cleveland BioLabs' IND for CBLB-502

Oct. 20, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...